Cardiovascular Revascularization Medicine
Volume 9, Issue 4 , Pages 218-223 , October 2008

Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents

  • James A. Shaw

      Affiliations

    • Department of Cardiology of The Alfred Hospital, Melbourne, Australia
    • Baker Heart Research Institute, Melbourne, Australia
    • Corresponding Author InformationCorrresponding author. Department of Cardiology Alfred Hospital and Baker Heart Research Institute, Commercial Rd, Melbourne, Australia. Tel.: +61 3 9076 3321; fax: +61 3 90762461.
    • ,
  • Nick Andrianopoulos

      Affiliations

    • Department of Epidemiology and Preventive Medicine, NHMRC Center of Clinical Research Excellence in Therapeutics, Monash University, Melbourne, Australia
    • ,
  • Stephen Duffy

      Affiliations

    • Department of Cardiology of The Alfred Hospital, Melbourne, Australia
    • Baker Heart Research Institute, Melbourne, Australia
    • ,
  • Anthony S. Walton

      Affiliations

    • Department of Cardiology of The Alfred Hospital, Melbourne, Australia
    • Department of Cardiology of The Western Hospital, Melbourne, Australia
    • ,
  • David Clark

      Affiliations

    • Department of Cardiology of The Austin Hospital, Melbourne, Australia
    • ,
  • Robert Lew

      Affiliations

    • Department of Cardiology of The Frankston Hospital, Melbourne, Australia
    • ,
  • Martin Sebastian

      Affiliations

    • Department of Cardiology of The Geelong Hospital, Melbourne, Australia
    • ,
  • Gishel New

      Affiliations

    • Department of Cardiology of The Box Hill Hospital, Melbourne, Australia
    • ,
  • Angela Brennan

      Affiliations

    • Department of Epidemiology and Preventive Medicine, NHMRC Center of Clinical Research Excellence in Therapeutics, Monash University, Melbourne, Australia
    • ,
  • Chris Reid

      Affiliations

    • Department of Epidemiology and Preventive Medicine, NHMRC Center of Clinical Research Excellence in Therapeutics, Monash University, Melbourne, Australia
    • ,
  • Andrew E. Ajani

      Affiliations

    • Department of Epidemiology and Preventive Medicine, NHMRC Center of Clinical Research Excellence in Therapeutics, Monash University, Melbourne, Australia
    • Department of Cardiology of The Royal Melbourne Hospital, Melbourne, Australia
    • University of Melbourne, Melbourne, Australia
    • ,
  • On behalf of the Melbourne Interventional Group

Received 21 January 2008 ,Revised 6 May 2008 ,Accepted 8 May 2008.

Reference 

  1. Luft FC. Renal disease as a risk factor for cardiovascular disease. Basic research in cardiology. 2000;95(Suppl 1):I72–I76
  2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305
  3. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285–1295
  4. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9(12 Suppl):S16–S23
  5. McCullough PA. Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med. 2002;3(2):71–76
  6. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13–20
  7. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344(25):1879–1887
  8. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315–1323
  9. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221–231
  10. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356(10):1020–1029
  11. Yan BP, Ajani AE, Duffy SJ, New G, Horrigan M, Szto G, et al. Use of drug-eluting stents in Victorian public hospitals. Med J Aust. 2006;185(7):363–367
  12. Ajani AE, Szto G, Duffy SJ, Eccleston D, Clark DJ, Lefkovits J, et al. The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project. Heart Lung Circ. 2006;15(1):44–47
  13. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 1990;82(4):1193–1202
  14. Rubenstein MH, Harrell LC, Sheynberg BV, Schunkert H, Bazari H, Palacios IF. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?. Circulation. 2000;102(24):2966–2972
  15. Rubenstein MH, Sheynberg BV, Harrell LC, Schunkert H, Bazari H, Palacios IF. Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure. Am J Cardiol. 2001;87(7):856–860
  16. Walsh CR, O'Donnell CJ, Camargo CA, Giugliano RP, Lloyd-Jones DM. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J. 2002;144(6):1003–1011
  17. Shlipak MG. Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med. 2003;138(11):917–924
  18. Naidu SS, Selzer F, Jacobs A, Faxon D, Marks DS, Johnston J, et al. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol. 2003;92(10):1160–1164
  19. Chew DP, Bhatt DL, Robbins MA, Penn MS, Schneider JP, Lauer MS, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation. 2001;104(9):992–997

PII: S1553-8389(08)00210-8

doi: 10.1016/j.carrev.2008.05.002

Cardiovascular Revascularization Medicine
Volume 9, Issue 4 , Pages 218-223 , October 2008

Article Tools

* Image Usage & Resolution